Gender
|
Male
|
34
|
81.0
|
Female
|
8
|
19.0
|
Age (years)
|
60 ~ < 65
|
9
|
21.4
|
65 ~ < 70
|
18
|
42.9
|
70 ~ < 75
|
11
|
26.2
|
≥ 75
|
4
|
9.5
|
ECOG
|
0
|
25
|
59.5
|
1
|
17
|
40.5
|
BMI
|
Low (< 18.5 kg/m2)
|
5
|
11.9
|
Normal (18.5 ~ < 24 kg/m2)
|
22
|
52.4
|
Overweight (24 ~ < 27 kg/m2)
|
10
|
23.8
|
Obesity (27 ~ < 30 kg/m2)
|
3
|
7.1
|
Severe obesity (≥ 30 kg/m2)
|
1
|
2.4
|
Unknown
|
1
|
2.4
|
Disease status
|
Recurrent
|
4
|
9.5
|
Newly diagnosed
|
38
|
90.5
|
HER2 status
|
HER2 positive
|
7
|
16.7
|
HER2 negative
|
30
|
71.4
|
Unknown
|
5
|
11.9
|
Metastatic site
|
Retroperitoneal lymph nodes
|
25
|
59.3
|
Supraclavicular lymph nodes
|
16
|
38.1
|
Mediastinal lymph nodes
|
12
|
28.6
|
Liver
|
10
|
23.8
|
Peritoneal
|
10
|
23.8
|
Lung
|
10
|
23.8
|
Adrenal gland
|
2
|
4.8
|
Bone
|
1
|
2.4
|
Ovary
|
1
|
2.4
|
Existing physical illness
|
Hypertension
|
9
|
21.4
|
Diabetes
|
5
|
11.9
|
Coronary heart disease
|
5
|
11.9
|
Cerebral infarction
|
3
|
7.1
|
Carotid artery stenosis
|
2
|
4.8
|
Arrhythmia
|
2
|
4.8
|
Liver cirrhosis
|
1
|
2.4
|